Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Cervical Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Randomized, Phase 3, Double-Blind Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer (KEYNOTE-A18 / ENGOT-cx11/ GOG-3047)

  • Details

ClinicalTrials.gov ID: NCT04221945
Diagnosis Type: Cervical Cancer
USOR Number: 20150

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.(950P1V02)

  • Details

ClinicalTrials.gov ID: NCT03872947
Diagnosis Type: Peritoneal Cancer
USOR Number: 21304

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.(950P1V02)

  • Details

ClinicalTrials.gov ID: NCT03872947
Diagnosis Type: Peritoneal Cancer
USOR Number: 21304

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 754-1256

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 2 Study of VS-6766 (Dual RAF/MEK Inhibitor) Alone and In Combination with Defactinib (FAK Inhibitor) in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)(VS-6766-201) (GOG 3052)

  • Details

ClinicalTrials.gov ID: NCT04625270
Diagnosis Type: Ovarian Cancer
USOR Number: 20298

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

(ALKS 4230-007/GOG-3063) A Phase 3, Multicenter, Open-Label, Randomized Study of Nemvaleukin Alfa in Combination With Pembrolizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARTISTRY-7)

  • Details

ClinicalTrials.gov ID: NCT05092360
Diagnosis Type: Peritoneal Cancer
USOR Number: 21457

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

(ALKS 4230-007/GOG-3063) A Phase 3, Multicenter, Open-Label, Randomized Study of Nemvaleukin Alfa in Combination With Pembrolizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARTISTRY-7)

  • Details

ClinicalTrials.gov ID: NCT05092360
Diagnosis Type: Peritoneal Cancer
USOR Number: 21457

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 754-1256

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 2 Trial of MRTX849 Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation (849-007)

  • Details

ClinicalTrials.gov ID: NCT04613596
Diagnosis Type: Lung Cancer
USOR Number: 20270

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Breast Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 2, Single-Arm, Open-Label Study of Trilaciclib Administered Prior to Sacituzumab Govitecan-hziy in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer Who Received at Least Two Prior Treatments, at Least One in the Metastatic Setting (G1T28-213)

  • Details

ClinicalTrials.gov ID: NCT05113966
Diagnosis Type: Breast Cancer
USOR Number: 21448

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Breast Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

A Phase 2, Single-Arm, Open-Label Study of Trilaciclib Administered Prior to Sacituzumab Govitecan-hziy in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer Who Received at Least Two Prior Treatments, at Least One in the Metastatic Setting (G1T28-213)

  • Details

ClinicalTrials.gov ID: NCT05113966
Diagnosis Type: Breast Cancer
USOR Number: 21448

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 754-1256

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1/2 Study of VS-6766 in Combination with Sotorasib in Patients with KRAS G12C mutant Non-Small Cell Lung Cancer (NSCLC) (RAMP 203) (VS-6766-203)

  • Details

ClinicalTrials.gov ID: NCT05074810
Diagnosis Type: Lung Cancer
USOR Number: 21498

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page
1 2 3 7